Clinical trials
Recruiting Carcinoma, Ovarian Epithelial trials in China
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
15 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2021 | 1 |
| 2022 | 1 |
| 2023 | 1 |
| 2024 | 2 |
| 2025 | 5 |
| 2026 | 5 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Recruiting | 15 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| AstraZeneca | 3 |
| Beijing Biotech | 3 |
| Anhui Provincial Hospital | 1 |
| Daiichi Sankyo | 1 |
| Peking University Third Hospital | 1 |
| Second Affiliated Hospital of Wenzhou Medical University | 1 |
| Shanghai Gynecologic Oncology Group | 1 |
| Shantou University Medical College | 1 |
| Sichuan Baili Pharmaceutical Co., Ltd. | 1 |
| The First Hospital of Jilin University | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Carcinoma, Ovarian Epithelial | 15 |
| Fallopian Tube Neoplasms | 8 |
| Ovarian Neoplasms | 6 |
| Recurrence | 2 |
| Lymphatic Metastasis | 1 |
Trials
Showing 1 to 15 of 15. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.